NTRA FY 2021 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

FY 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$625M+60.0% YoY

Gross Profit

$307M49.1% margin

Operating Income

-$468M-74.8% margin

Net Income

-$472M-75.4% margin

EPS (Diluted)

$-5.21

Cash Flow

Operating Cash Flow

-$335M

Free Cash Flow

-$376M

Stock-Based Comp.

$115M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$583M

Stockholders' Equity

$653M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$625M	$391M	+60.0%
Gross Profit	$307M	$187M	+63.9%
Operating Income	-$468M	-$216M	-116.5%
Net Income	-$472M	-$230M	-105.3%